As the Director for the Center for Value-Based Pharmacy Initiatives with UPMC Health Plan, Dr. Good has implemented innovative value based contracts for pharmaceuticals. Prior to coming to UPMC, he was the Chair of the Medical Advisory Panel for Pharmacy Benefits Management and Co-Director of the Center for Medication Safety for nearly 20 years. He is a frequent speaker at national conferences and is widely published in the areas of drug safety, appropriate prescribing, conflicts of interest, and cost-effectiveness.
- BS, Biochemistry, University of Maryland, 1979
- MD, George Washington University, 1983
- Residency in Internal Medicine, University of Pittsburgh, 1986
- MPH, Epidemiology, University of Pittsburgh, 1993
Education & Training
Good CB, Parekh N, Fischer K, Manolis C, Schuster J, Shrank WH. Treating pain: The cannabis conundrum. Annals of Internal Medicine. 2019; 170(2):23.
Hernandez I, Good CB, Shrank W, Gellad WF. Trends in Medicaid prices, market share, and spending on long-acting insulins, 2006-2018. Journal of the American Medical Association. 2019; 321(16):1627-1629.
Gellad WF, Good CB. Adalimumab and the challenges for biosimilars. Journal of the American Medical Association. 2019.
Desai RJ, Good MM, San-Juan-Rodrigquez A, Henriksen A, Cunningham F, Hernandez I, Good CB. Varenicline and nicotine replacement use associated with US Food and Drug Administration drug safety communications. JAMA Network Open. 2019; 2(9):e1901626.
- Outstanding Physician of the Year Award, VA Pittsburgh Healthcare System, 2005
- Excellence in Education Award, School of Medicine, University of Pittsburgh, 2006
- Mark Wolcott Award for Excellence in Clinical Care Leadership, Department of Veterans Affairs, 2006
- Under Secretary for Health “Advancement of Pharmacy Programs” National Award, Department of Veterans Affairs, 2010
